The multifunctional mitochondrion and disease
In addition to energy production, mitochondria also conduct other key cellular tasks, including the regulation of cytosolic calcium levels (29) and tissue oxygen gradients (104) , H 2 O 2 signalling (11) , and the modulation of apoptosis (12) . Importantly, mitochondria also receive, integrate and transmit signals, thus playing a critical role in cellular responses to a variety of stimuli (38) . In consequence, mitochondrial damage may lead to the impairment of various aspects of tissue functioning. Accumulating evidence supports the notion that malfunctioning mitochondria strongly participate in the pathogenesis of cardiovascular damage (43) , associated with hypertension (26, 27, 107) , cardiac failure, the metabolic syndrome and obesity (118) , diabetes mellitus (23, 114), renal disease (44) , atherosclerosis (96), as well as aging (25, 36, 46, 64) .
Mitochondria and angiotensin II (Ang-II)
Ang-II, a key component of the RAS, plays a pivotal role in the regulation of blood pressure, volume, and electrolyte balance. Derangements of the RAS contribute to hypertension and target-organ injury. Ang-II can induce oxidant stress by enhancing the generation of both NO (88) and NAD(P)H oxidase-derived superoxide (92) , thereby promoting peroxynitrite formation. Ang-II can also induce eNOS uncoupling, i.e. switching from NO to superoxide production (74) . In addition, Ang-II was found to stimulate mitochondrial reactive oxygen species (mtROS) production.
In rat endothelial cells, Ang-II-induced mtROS generation activates redox-sensitive NF-kappaB, which is followed by stimulation of vascular cell adhesion molecule-1 expression, a cytokine involved in atherosclerosis lesion formation (89). In mice, acute (24 h ) and chronic (14 day) Ang-II infusion led to decreased cardiac expression of mitochondrial electron transport chain and Krebs cycle genes (65) , supporting previous observations that indicated a role for Ang-II in the depression of mitochondrial energy metabolism (16, 94, 99) .
Moreover, in rat vascular smooth muscle cells and aorta in vivo Ang-II lowers mitochondrial membrane potential as a result of stimulation of mtROS production (62). In cat myocardium, the response to stretch comprises the activation of NAD(P)H oxidase by Ang-II leading to mtROS release (13). Recently, it was shown that the molecular mechanisms involved in Ang-II-mediated mitochondrial dysfunction (increased mitochondrial H 2 O 2 production, and decreased mitochondrial glutathione, state 3 respiration, and membrane potential) include protein kinase C activation, which in turn activates bovine aortic endothelial cell NAD(P)H oxidase and stimulates peroxynitrite formation (28) . Notably, mitochondrial dysfunction was associated with endothelial dysfunction as indicated by the decrease of endothelial NO production (28) .
Another link between Ang-II and mitochondrial dysfunction is suggested by data showing that mitochondrial p66Shc plays a crucial role in Ang-II-induced myocardial remodelling (42) . p66Shc -a protein partially localized in the mitochondrial intermembrane space-was suggested to contribute to mitochondrial ROS production by substracting electrons from cytochrome c, and transferring them to oxygen to generate superoxide.
Other evidence indicates a direct interaction between Ang-II and mitochondrial components.
125 I-labeled Ang-II was detected in heart, brain and smooth muscle cell mitochondria and nuclei (91, 98) . In rat adrenal zona glomerulosa, renin, angiotensinogen and ACE were detected within intramitochondrial dense bodies (85) , and in rat cerebellar cortex mitochondria Ang-II immunoreactivity was also found (32) . Therefore, it is apparent that the effects of Ang-II on mitochondria may be either a) dependent on NAD(P)H oxidase activation or b) direct.
In this line, we have shown that in rodent models of hypertension, diabetes and aging, Ang-II blockade not only attenuates oxidant production, but also improves mitochondrial function (23, (25) (26) (27) . In support of the proposed direct actions of AngII, recent data showed that in rat embryonic vascular smooth muscle cells Ang-II can exert effects from the cell interior, independently from extracellular actions, and seemingly through binding to intracellular receptors different from AT1 and AT2 receptors (35), or to AT1 nuclear receptors (69) .
Internalization of Ang-II can be mediated by internalization of AT1 receptors bound to Ang-II, as was reported in rat aortic smooth muscle cells (1), hepatocytes (54), human vascular smooth muscle cells (8) and renal proximal tubule epithelial cells (103) In some cells, Ang-II internalization is mediated by megalin, although this mechanism is thought to mark internalized Ang-II for decomposition (39).
2a. Mitochondria and angiotensin II inhibitors
The renal and cardiac benefits of ACE inhibitors and Ang-II type I (AT1) receptor blockers in hypertension, cardiovascular disease and diabetes patients (10, 22, 86) seem to be -at least partly-independent from their blood pressure lowering actions (10, 22, 82, 84) . In this regard, RAS inhibitors were proposed to act as a magic bullet against oxidant stress (79) .
To further investigate the cellular mechanisms responsible for the protective actions of RAS inhibitors, we set forth to study the effects of these drugs on mitochondria. First, we showed that ACE-inhibition (enalapril) in aging mice prevented the lowering of mitochondrial number (34), attenuated age-related mitochondrial structure changes in myocardiocytes and hepatocytes (unpublished observation), and significantly increased animal survival (34) , suggesting that natural aging mechanisms had been altered in enalapril-treated animals. The latter action on mice survival is in agreement with recent data in rats (5) . Later, we found that in aging rats long-term treatment with enalapril or AT1-receptor blocker (losartan) improved kidney mitochondria functioning, when compared with mitochondria isolated from untreated old rats (25). In the same study, a general improvement in mitochondrial number and structure was observed, indicating that both RAS inhibitor strategies protect mitochondrial components and function from certain effects of aging. In another study, we showed that in spontaneously hypertensive rats RAS inhibition -but not Ca 2+ channel blockade (amlodipine)-protects kidney mitochondria from hypertension-related damage (26, 27) . Furthermore, in streptozotocin-diabetic rats -a model of type-1 diabetes -losartan, but not amlodipine, protected kidney mitochondria function without normalizing plasma glucose (23). In accordance with our findings in the kidney, Ang-II inhibition was shown to improve cardiac mitochondria energy production (75, 76, 80) , and in captopril-treated diabetic rats the expression of genes related to energy production was up-regulated (19) . Concerning the potential factor(s) that may mediate the effects of Ang-II inhibitors on mitochondrial function, a recent study suggests that mitochondrial NO may contribute to the mitochondrial effects of enalapril in the kidney (87). Other studies showed that AT1-receptor blockers can modulate uncoupling protein (UCP) mRNA levels in mouse brown adipose tissue (3) and rat liver (21) , or UCP protein content in rat kidney (25, 87). UCPs, by uncoupling mitochondrial electron transport from ATP production can affect mitochondrial energy output, as well as modulate mitochondrial oxidant production. Therefore, ATP-producing mitochondria are needed to support the energy requirements of cytoskeletal structure dynamics. Conversely, mitochondria need to interact with cytoskeletal elements to achieve normal organelle motility, morphology, localization and function (9) . Thus, in multicellular eukaryotes mitochondria are transported along the microtubules, whereas in certain cells -such as neurons-actin filaments sustain short length mitochondrial displacements (37) . Also, actin filaments mediate the immobilization of mitochondria at intracellular locations of intense neuronal ATP consumption (9) , and the association of mitochondria with actin filaments seems to facilitate the recruitment of pro-apoptotic cytosolic proteins to initiate apoptosis (101) . It is apparent that adequate distribution of mitochondria participates in sustaining organelle function and is necessary for cell survival (37). 7 The profoundly curved mitochondrial morphology is preserved -at least partly-by attachment of mitochondria to the cytoskeletal tubulin and actin filaments (113) , and the interaction between mitochondria and vimentin, an intermediate filament protein, also contributes to maintain mitochondrial morphology and organization (102) .
Furthermore, experimental depression of actin turnover stimulates the release of reactive oxygen species (ROS) from yeast mitochondria, thereby promoting apoptosis (40) . This behavior indicates that the inability to reorganize the actin cytoskeleton in response to external or internal signals leads to the impairment of cell function. In mammalian cells, circumstantial evidence also points to the involvement of altered actin dynamics in prompting apoptosis, which seems to be mediated by increased mitochondrial ROS production (40) .
Finally, because cytoskeletal filaments provide both a direct mechanical connection between most cell structures, and an extense negatively charged binding site for signaling molecules in response to activation of membrane receptors, the cytoskeleton participates in the transmission of signals from the plasma membrane to the cell interior (53).
Considering the above mentioned functions, it is likely that disturbance of the cytoskeleton interferes with normal mitochondrial and cellular function and may lead to pathological consequences. Interestingly, abundant evidence shows that Ang-II induces cytoskeletal changes.
3a.i. Ang-II and the cytoskeleton
In addition to its role as a vasoactive peptide, Ang-II is a growth factor that variously regulates the genetic expression of ECM proteins, other growth factors, cytokines, cell adhesion molecules and vasoactive agents, in vascular, cardiac, and kidney mesangial cells (59) , and in this way can contribute to the pathogenesis of vascular remodeling in hypertension and atherosclerosis. Of note, Ang-II (93) induces changes in cytoskeletal filament organization (filament polymerization, stress fiber formation and assembly of focal adhesions) (for focal adhesions see 3c. The cytoskeleton-ECM connexion) (117) , that also participate in pathologic vascular alteration. Thus, in rat vascular smooth muscle cells (VSMC) Ang-II stimulates the formation of actin stress fibers and focal adhesions as a result of c-Src activation (51) , and induces polymerization and contraction of actin filaments as a result of p38 MAP kinase activation by a pathway that involved ROS generation, but not the classic AT1 receptor signaling 8 pathways (no activation of PKC or Tyr kinases) (72) . In cultured rat VSMC, Ang II-stimulates tyrosine phosphorylation of paxillin and focal adhesion kinase -two components of actin-associated focal adhesions-via AT1 receptors (81), and these responses involve PKC-dependent and independent pathways and is accompanied by cytoskeletal reorganization (formation of actin stress fiber sand focal adhesions) (108) Conversely, disturbance of actin organization suppresses Ang-II mediated signaling (41) .
In addition, Ang-II prompts the phenotypic conversion of tubulointerstitial (115) and cardiac fibroblasts (14) into myofibroblasts, that express α-smooth muscle actin (α-SMA) which is not expressed in normal fibroblasts. Ang-II also stimulates the expression of α-SMA in glomerular mesangial cells (55) , and human VSMC (2) and the intermediate filament protein desmin in glomerular epithelial cells (55) . In agreement with the above data, chronic enalapril treatment prevented age-(49), and hyperoxaluria-related (106) α-SMA accumulation in rodent renal interstitium. Also, glomerular, and cortical and medullary interstitial α-SMA staining was significantly lower in quinapril-treated than in untreated obese Zucker rats (90) .
Summarizing, available evidence indicates that a) mitochondrial function is altered in response to both cytoskeletal disturbance and Ang-II, and b) Ang-II changes cytoskeletal organization. Therefore, it is possible to hypothesize that the depression of mitochondrial energy metabolism brought about by Ang-II is preceded by Ang-II-induced derangement of the cytoskeletal filament network.
3b. The ECM influences mitochondrial morphology and function
The extracellular matrix (ECM) plays a key role in the maintenance of tissue structure and function. ECM turnover is largely regulated by firmly controlled matrix metalloproteases (MMP) activities. Abnormal turnover of matrix components is associated with disease (71) . Although ECM remodeling is critical for proper development and tissue repair, faulty remodeling contributes to tissue fibrosis. Various high blood pressure conditions display cardiovascular and renal remodeling, which are manifested by tissue hypertrophy and inadequate changes in the quantity and quality of the ECM (17, 30) , and lead to the pathogenesis of fibrotic diseases. Accumulating evidence shows that mitochondria may act as sensors for changes in ECM composition. Thus, in genetically modified mice, skeletal muscle collagen VI deficiency resulted in structural mitochondria alterations -abnormal cristae and modified matrix density-and mitochondrial dysfunction, leading to muscle cell apoptosis (50). Fibronectin, another ECM protein, conveys survival signals for many cell types, protecting them from apoptosis (56). Accordingly, knockdown of fibronectin mRNA expression induced apoptosis in rat mesangial cells, and mitochondria-derived signaling was involved in the response (119) . Also, under oxidative stress conditions, MMP-2 negatively regulates cardiac mitochondria function (122) . Conversely, alteration of mitochondrial functioning triggers ECM changes. Thus, oxidative phosphorylation deficiency activates the transcription of ECM remodeling genes (including MMP) in cultured osteosarcoma cells (110) . This evidence indicates that a delicate relationship seems to exist between the ECM and mitochondria. As described above for its ability to modify cytoskeletal organization, Ang-II also alters the protein composition of the ECM.
3.b.i. Ang-II and the ECM
As already mentioned in Section 3.a.i. (Ang-II and the cytoskeleton) Ang-II is involved in the regulation of ECM protein gene expression. In the heart, ECM proteins are mainly produced by fibroblasts; therefore fibroblasts play a crucial role in cardiac fibrosis development. In cultured rat cardiac fibroblasts Ang-II increases the synthesis and secretion of collagen (18), fibronectin and laminin (52) , and osteopontin expression (4) . When infused into rats, Ang II induces the increase of left ventricular fibronectin, collagens I and III mRNAs (61).
Rat vascular smooth muscle cells exposed to Ang-II display increased levels of collagen protein (57), fibronectin (100), laminin and tenascin (97) mRNA and protein. In vivo, infusion of Ang-II increases fibronectin mRNA and protein in rat aorta (60) .
Ang-II also stimulates the synthesis of ECM collagens, fibronectin and laminin by renal mesangial cells, tubular cells and interstitial fibroblasts. Seemingly, these effects are mediated by TGF-β and plasminogen activator inhibitor type 1 (PAI-1), among other factors (73) . Pharmacological inhibition of the RAS attenuates ECM deposition in the kidney and in the vasculature (for review see (59) . In accordance with Ang-II actions on ECM production, chronic enalapril treatment reduced age-associated renal (49) and myocardial (48) collagen deposition in female mice, hyperoxaluria-related TGF-β and collagen type III immunostaining in the tubulointerstitial area (106), cavernous tissue collagen type III immunolabeling in spontaneously hypertensive rats (105) , and collagen accumulation in the heart, liver and kidneys of streptozotocin-diabetic rats (24) .
At this point a new element can be added to the hypothesis proposed in Section 3.a.i., as follows. A body of evidence indicates that a) mitochondrial function is altered in response to cytoskeletal disturbance, ECM disturbance and Ang-II, and b) Ang-II changes both cytoskeletal and ECM organization. Therefore, it is possible to hypothesize that the depression of mitochondrial energy metabolism brought about by Ang-II is preceded by Ang-II-induced derangement of the cytoskeletal filament network and/or ECM organization.
3c. The cytoskeleton-ECM connexion.
The cytoskeleton and the ECM are structurally and functionally connected through the integrins. Integrins are plasma membrane cell adhesion proteins that act as matrix receptors, and bind ECM proteins -including collagen, fibronectin, vitronectin and laminin-to the actin cytoskeleton. Importantly, binding of integrins to their ligands activates intracellular signaling pathways that provide the cells with critical information concerning the nature of the surroundings (7), allowing them to respond to the environment. Integrins not only sense the biochemical composition but also the mechanical properties of the ECM. Integrin-mediated cell adhesion signaling conveys information that influences the growth, division, differentiation, morphology, survival, programmed death, and mobility properties of the cell (66) . Integrin receptors cluster at clearly defined ranges of cell contact with the ECM known as focal adhesions. Focal adhesions are large macromolecular assemblies involved in cell anchorage, that also function as biochemical signalling hubs by concentrating and directing signalling proteins. One of the earliest events in response to integrin stimulation is protein phosphorylation that results from activation of protein-tyrosine kinases, such as members of the Src-family and the cytoplasmic focal adhesion protein-tyrosine kinase (FAK) (95) . Other intracellular second message systems that are activated upon binding of integrins to their ligands include mitogen-activated protein (MAP) kinases, Rho family GTP-binding proteins, calcium channels, phosphatidylinositol-4,5-bisphosphate, phospholipase-C, the Na/H antiporter, tyrosine and serine/threonine kinases, phosphatases, and cyclin D1. Integrins also transduce messages from the inside-out, whereby the intracellular milieu is able to regulate the adhesive activity of integrins.
Of note, integrin-mediated signaling was recently found to modify mitochondrial function, leading to changes in gene expression and without triggering apoptosis (116) . In this context, Ang-II was shown exert intracellular effects by inducing integrin/focal adhesion changes.
3.c.i Ang-II and integrins
Abundant evidence indicates that the effects of Ang II on ECM formation involve changes in integrin/focal adhesion signalling. In rat cardiac fibroblasts, Ang-II -by acting on its AT1 receptor-enhances alpha(v), beta(1), beta(3), and beta (5) integrins, osteopontin, and alpha-actinin mRNA and protein levels, and this effect is accompanied with enhanced cell attachment to the ECM and phosphorylation of focal adhesion kinase (58) . In cultured rat VSMC, Ang II stimulates paxillin and focal adhesion kinase phosphorylation via AT1 receptors (81). In adrenal glomerulosa cells, Ang II seems to inhibit proliferation and initiation of steroidogenesis by interfering with extracellular matrix/integrin signalling, at the level of paxillin binding to focal adhesions, which activates RhoA/B and Rac and disrupts actin stress fiber organization. (83) . In human umbilical vein endothelial cells, Ang II stimulates integrin beta(3) expression in part by activating NF-kappaB (67) . Importantly, studies in vivo using genetically altered mice lacking alpha(1)-integrin showed that signalling through alpha(1)beta(1)-integrin and focal adhesions is involved in Ang-II-induced vascular hypertrophy (70).
3.c.ii. Ang-II, TGF-β, the ECM, the cytoskeleton and mitochondria
In addition to the varied effects mentioned in Section 3a.i., Ang-II plays a pivotal role in fibrosis -at least in part-by stimulating transforming growth factor-β1 (TGF-β1) production and enhancing TGF-β1 signaling in activated human hepatic stellate cells and rat cardiac fibroblasts (120), human lung fibroblasts (109), human kidney tubular epithelial cells (15) , and human myocardium (63) . TGF- β1 is a pleiotropic cytokine that plays a crucial role in the regulation of ECM assembly and remodeling, mainly by stimulating both the expression of collagens, fibronectin and proteoglycans, and the production of proteases that inhibit ECM breakdown.
Persistent activation of TGF-β receptors leads to the anomalous connective tissue deposition associated to fibrotic disease (112) . In mouse VSMC, the induction of TGF-β1 and collagen type I release by Ang II is dependent on alpha(v)beta(3)-integrin signalling (6) . In rat cardiac fibroblasts, Ang II-induced expression of fibronectin and TGF-β is mediated by transactivation and downstream signalling of the epidermal growth factor receptor, and TGF-β contributes to the modulation of fibronectin mRNA stabilization (77) . In the human myocardium, Ang-II seems to increase collagen expression indirectly by first increasing TGF-β1 expression (63) .
Appart from inducing ECM changes, binding of TGF-β to plasma membrane receptors activates intracellular signaling pathways that are involved in the regulation of actin cytoskeleton reorganization (111) (78). These actin filament rearrangements contribute to TGF-β effects on cell growth and differentiation (31) .
Interestingly, TGF-β seems to interact with mitochondria. Recently, TGF- β1 was found to induce growth arrest and acquisition of senescent phenotypes in lung epithelial cells, and this effect was mediated by decreased mitochondrial complex IV activity and the subsequent increase of mitochondrial ROS production (121) .
Treatment of fetal hepatocytes with TGF- β1 was followed by increased mitochondrial ROS generation, lowering of mitochondrial membrane potential and finally apoptosis (47) . Also, TGF- β1 was found within mitochondria in rat and mouse cardiac myocytes and rat hepatocytes (45) , and in mouse T lymphocytes (20) where it seems to contribute to maintain mitochondrial structure and function.
These findings point to TGF- β1 as a potential link between Ang-II, ECM and cytoskeleton derangements, and mitochondrial dysfunction. Interestingly, Ang-II was recently shown to stimulate nuclear AT1a receptors directly to induce TGF-β1 transcription in rat renal cortical nuclei (68) . Summary and hypothesis A potential limitation of this proposal is that the results compiled in the present report were obtained in different tissues or cellular systems, by using various experimental models (See Tables 1 and 2) Further research is needed to confirm the veracity of the present proposal, which if proven to be correct would underscore the relevance of inhibiting the RAS to preserve mitochondrial structure and function in those conditions associated to the enhancement of Ang-II signalling. 
